Clinical trials recruiting for SCHIZOPHRENIA 1 (Disorder)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Xanomeline and trospium chloride (KarXT) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 2 |
Top cities
Self-screener
Recruiting trials
- A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
- Disorders of the Sense of Self and Physical Activity
- Multi-target TMS for Schizophrenia Negative Symptoms
- Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
- PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
- TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
- The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
Related conditions
Trials recruiting for SCHIZOPHRENIA 1 (Disorder) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for SCHIZOPHRENIA 1 (Disorder) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.